Radiological and Laboratory Findings of Patients with COVID-۱۹ Infection at the Time of Admission

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 273

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJP-16-2_006

تاریخ نمایه سازی: 14 بهمن 1400

چکیده مقاله:

Background & Objective: Diagnosis of coronavirus disease ۲۰۱۹ (COVID-۱۹) can be challenging, especially when the real­time quantitative reverse transcription polymerase chain reaction (RT-PCR) is not available or it is negative. In this study, we evaluated imaging and laboratory findings in a group of patients with a multidisciplinary diagnosis of COVID-۱۹ pneumonia. Methods: A total of ۱۶۳ patients with a clinical diagnosis of COVID-۱۹ pneumonia admitted to a specialised respiratory centre in Tehran, Iran were enrolled in this study. The distribution and characteristics of presenting radiological and laboratory findings were evaluated and the relationship to the outcome was investigated. Results: RT­PCR was positive in ۹۲ patients. The diagnosis of COVID-۱۹ in RT-PCR negative patients was made on clinical and radiological grounds (n=۷۱). Also, ۲۴ (۱۴.۷%) patients died. The common computed tomography (CT) scan findings included ground-glass (۹۴%) and consolidating opacification (۱۲%), mainly in the lower lobes (۹۰%). Peripheral and central lung changes were observed in ۹۰% and ۵۲% of patients, respectively. Lymphopenia, positive CRP, and raised LDH were present in ۳۲%, ۶۵%, and ۹۶% of cases, respectively. A raised LDH of >۵۰۰U/L was the best predictor of death in these patients (R۲=۰.۶۶۲۳; OR=۲۴.۴). Other markers of outcome were male gender, age (>۵۰ years), lymphopenia, and severe CXR changes. Conclusion: Diagnosis of COVID-۱۹ can be challenging, and a multidisciplinary approach is often needed. Whilst RT-PCR is the standard diagnostic test, a negative test should be interpreted with caution. Blood tests and imaging can be useful in the diagnosis, monitoring, and risk assessment in patients with COVID-۱۹. 

نویسندگان

- -

Royal Brompton and Harefield NHS Foundation Trust, Sydney St, London, UK

- -

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

- -

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

- -

Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

- -

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

- -

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

- -

Medical Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Chen N, Zhou M, Dong X, Qu J, Gong F, ...
  • Fang Y, Zhang H, Xie J, Lin M, Ying L, ...
  • Shi H, Han X, Jiang N, Cao Y, Alwalid O, ...
  • Huang C, Wang Y, Li X, Ren L, Zhao J, ...
  • نمایش کامل مراجع